{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:28:38Z","timestamp":1791494918557,"version":"4.3.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-03913-x","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:35:26Z","timestamp":1772159726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Psychedelic therapy and cultural humility"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1032-4928","authenticated-orcid":false,"given":"Alex","family":"Gearin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3046-7464","authenticated-orcid":false,"given":"Jennifer","family":"Docherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1277-0814","authenticated-orcid":false,"given":"Emmanuel Hei-Lok","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tanuseputro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"3913_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1353\/hpu.2010.0233","volume":"9","author":"M Tervalon","year":"1998","unstructured":"Tervalon M, Murray-Garc\u00eda J. Cultural humility versus cultural competence: a critical distinction in defining physician training outcomes in multicultural education. J health care poor underserved. 1998;9:117\u201325.","journal-title":"J health care poor underserved"},{"key":"3913_CR2","doi-asserted-by":"publisher","first-page":"100410","DOI":"10.1016\/j.lana.2022.100410","volume":"18","author":"Y Celidwen","year":"2023","unstructured":"Celidwen Y, Redvers N, Githaiga C, Calamb\u00e1s J, A\u00f1a\u00f1os K, Chindoy ME, et al. Ethical principles of traditional Indigenous medicine to guide western psychedelic research and practice. Lancet Regional Health \u2013 Am. 2023;18:100410.","journal-title":"Lancet Regional Health \u2013 Am"},{"key":"3913_CR3","doi-asserted-by":"publisher","first-page":"100200","DOI":"10.1016\/j.anzjph.2024.100200","volume":"48","author":"B Sebben","year":"2024","unstructured":"Sebben B, Stone J, Sarris J, Perkins D, Mallie K, Barnett S, et al. Psychedelic medicine and cultural responsiveness: a call for aboriginal and torres strait islander engagement in Australian clinical trials and practice. Australian N ZealJ Public Health. 2024;48:100200.","journal-title":"Australian N ZealJ Public Health"},{"key":"3913_CR4","doi-asserted-by":"publisher","first-page":"102711","DOI":"10.1016\/j.eclinm.2024.102711","volume":"74","author":"ME Hughes","year":"2024","unstructured":"Hughes ME, Garcia-Romeu A. Ethnoracial inclusion in clinical trials of psychedelics: a systematic review. EClinicalMedicine. 2024;74:102711. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102711.","journal-title":"EClinicalMedicine"},{"key":"3913_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1556\/2054.2025.00436","volume":"9","author":"A Hodge","year":"2025","unstructured":"Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. T\u016b Wairua: development of an indigenous rongo\u0101 m\u0101ori approach to healing with psilocybin containing mushrooms. J Psychedelic Stud. 2025;9:369\u201384. https:\/\/doi.org\/10.1556\/2054.2025.00436.","journal-title":"J Psychedelic Stud"},{"key":"3913_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE. Psychedelics. Pharmacol Rev. 2016;68:264\u2013355.","journal-title":"Pharmacol Rev"},{"key":"3913_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","volume":"187","author":"RR Griffiths","year":"2006","unstructured":"Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006;187:268\u201383.","journal-title":"Psychopharmacology"},{"key":"3913_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/sj.npp.1395318","volume":"21","author":"GK Aghajanian","year":"1999","unstructured":"Aghajanian GK, Marek GJ. Serotonin and Hallucinogens. Neuropsychopharmacology. 1999;21:16\u201323.","journal-title":"Neuropsychopharmacology"},{"key":"3913_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","volume":"21","author":"TD McClure-Begley","year":"2022","unstructured":"McClure-Begley TD, Roth BL. The promises and perils of psychedelic pharmacology for psychiatry. Nat Rev Drug Discov. 2022;21:463\u201373.","journal-title":"Nat Rev Drug Discov"},{"key":"3913_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","volume":"30","author":"RR Griffiths","year":"2016","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30:1181\u201397.","journal-title":"J Psychopharmacol"},{"key":"3913_CR11","doi-asserted-by":"crossref","unstructured":"Grob CS, Bossis AP, Griffiths RR Use of the classic hallucinogen psilocybin for treatment of existential distress associated with cancer. In: Carr BI, Steel J, editors. Psychological Aspects of Cancer. Boston, MA: Springer US; 2013. p. 291\u2013308.","DOI":"10.1007\/978-1-4614-4866-2_17"},{"key":"3913_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0269881114555249","volume":"29","author":"P Gasser","year":"2015","unstructured":"Gasser P, Kirchner K, Passie T. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. J Psychopharmacol. 2015;29:57\u201368.","journal-title":"J Psychopharmacol"},{"key":"3913_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0269881119897615","volume":"34","author":"GI Agin-Liebes","year":"2020","unstructured":"Agin-Liebes GI, Malone T, Yalch MM, Mennenga SE, Pont\u00e9 KL, Guss J, et al. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J Psychopharmacol. 2020;34:155\u201366.","journal-title":"J Psychopharmacol"},{"key":"3913_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/09540261.2018.1482261","volume":"30","author":"S Ross","year":"2018","unstructured":"Ross S. Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress. Int Rev Psychiatry. 2018;30:317\u201330.","journal-title":"Int Rev Psychiatry"},{"key":"3913_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-019-0499-1","volume":"19","author":"E Falk","year":"2020","unstructured":"Falk E, Schlieper D, van Caster P, Lutterbeck MJ, Schwartz J, Cordes J, et al. A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study. BMC Palliat Care. 2020;19:1.","journal-title":"BMC Palliat Care"},{"key":"3913_CR16","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.21037\/apm.2019.09.09","volume":"9","author":"KWA Cheung","year":"2020","unstructured":"Cheung KWA, Chan PC, Lo SH. The use of ketamine in the management of refractory cancer pain in a palliative care unit. Ann Palliat Med. 2020;9:4478\u201389.","journal-title":"Ann Palliat Med"},{"key":"3913_CR17","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.18632\/oncotarget.13743","volume":"8","author":"W Fan","year":"2017","unstructured":"Fan W, Yang H, Sun Y, Zhang J, Li G, Zheng Y, et al. Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial. Oncotarget. 2017;8:2356\u201360.","journal-title":"Oncotarget"},{"key":"3913_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.psym.2014.05.005","volume":"56","author":"A Iglewicz","year":"2015","unstructured":"Iglewicz A, Morrison K, Nelesen RA, Zhan T, Iglewicz B, Fairman N, et al. Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases. Psychosomatics. 2015;56:329\u201337.","journal-title":"Psychosomatics"},{"key":"3913_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/NJH.0000000000001096","volume":"27","author":"M Miller","year":"2025","unstructured":"Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, et al. A rapid review of psychedelic-assisted therapy in the context of palliative care. J Hosp Palliat Nurs. 2025;27:67\u201373.","journal-title":"J Hosp Palliat Nurs"},{"key":"3913_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/02791072.2023.2255274","volume":"55","author":"M Graziosi","year":"2023","unstructured":"Graziosi M, Singh M, Nayak SM, Yaden DB. Acute subjective effects of psychedelics within and beyond weird contexts. J Psychoact Drugs. 2023;55:558\u201369.","journal-title":"J Psychoact Drugs"},{"key":"3913_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1213\/00000539-196405000-00013","volume":"43","author":"EC Kast","year":"1964","unstructured":"Kast EC, Collins VJ. Study of lysergic acid diethylamide as an analgestic agent. Anesth Analg. 1964;43:285\u201391.","journal-title":"Anesth Analg"},{"key":"3913_CR22","unstructured":"Cohen S LSD and the anguish of dying. Harpers Magazine. 1965:69\u201372."},{"key":"3913_CR23","first-page":"80","volume":"26","author":"E Kast","year":"1966","unstructured":"Kast E. LSD and the dying patient. Chic Med Sch Q. 1966;26:80\u20137.","journal-title":"Chic Med Sch Q"},{"key":"3913_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000467984","volume":"8","author":"S Grof","year":"1973","unstructured":"Grof S, Goodman LE, Richards WA, Kurland AA. LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsychiatry. 1973;8:129\u201344.","journal-title":"Int Pharmacopsychiatry"},{"key":"3913_CR25","first-page":"144","volume":"9","author":"WN Pahnke","year":"1969","unstructured":"Pahnke WN, Kurland AA, Goodman LE, Richards WA. LSD-assisted psychotherapy with terminal cancer patients. Curr Psychiatr Ther. 1969;9:144\u201352.","journal-title":"Curr Psychiatr Ther"},{"key":"3913_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/jamapsychiatry.2022.4101","volume":"80","author":"JS Siegel","year":"2023","unstructured":"Siegel JS, Daily JE, Perry DA, Nicol GE. Psychedelic drug legislative reform and legalization in the US. JAMA Psychiatry. 2023;80:77\u201383.","journal-title":"JAMA Psychiatry"},{"key":"3913_CR27","first-page":"Cd015383","volume":"9","author":"S Schipper","year":"2024","unstructured":"Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, et al. Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases. Cochrane Database Syst Rev. 2024;9:Cd015383.","journal-title":"Cochrane Database Syst Rev"},{"key":"3913_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","volume":"68","author":"CS Grob","year":"2011","unstructured":"Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry. 2011;68:71\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"3913_CR29","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol. 2016;30:1165\u201380.","journal-title":"J Psychopharmacol"},{"key":"3913_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.genhosppsych.2025.08.001","volume":"96","author":"ML Ross","year":"2025","unstructured":"Ross ML, Iyer R, Williams ML, Boughey M, O'Callaghan C, Hiscock R, et al. Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: a phase 2b randomized controlled trial. Gen Hospital Psychiatry. 2025;96:322\u201331.","journal-title":"Gen Hospital Psychiatry"},{"key":"3913_CR31","doi-asserted-by":"crossref","unstructured":"Fu C, Glasdam S. The \u2018good death\u2019 in mainland china - a scoping review. Int J Nurs Stud Adv. 2022;4:100069.","DOI":"10.1016\/j.ijnsa.2022.100069"},{"key":"3913_CR32","unstructured":"Luna LE, White SF, Metzner R Ayahuasca reader: encounters with the amazon's sacred vine. 2 ed. La Vergne: Synergetic Press; 2016."},{"key":"3913_CR33","doi-asserted-by":"crossref","unstructured":"Oram M The Trials of Psychedelic Therapy: LSD Psychotherapy in America: Johns Hopkins University Press; 2018.","DOI":"10.1353\/book.60680"},{"key":"3913_CR34","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jamapsychiatry.2022.2546","volume":"79","author":"DB Yaden","year":"2022","unstructured":"Yaden DB, Potash JB, Griffiths RR. Preparing for the bursting of the psychedelic hype bubble. JAMA Psychiatry. 2022;79:943\u20134.","journal-title":"JAMA Psychiatry"},{"key":"3913_CR35","first-page":"1","volume":"12\/15","author":"N Langlitz","year":"2022","unstructured":"Langlitz N. Psychedelic innovations and the crisis of psychopharmacology. BioSocieties. 2022;12\/15:1\u201322.","journal-title":"BioSocieties"},{"key":"3913_CR36","doi-asserted-by":"crossref","unstructured":"Gearin AK Global Ayahuasca: Wondrous Visions and Modern Worlds: Stanford University Press; 2024.","DOI":"10.1515\/9781503639843"},{"key":"3913_CR37","doi-asserted-by":"publisher","first-page":"e252853","DOI":"10.1001\/jamanetworkopen.2025.2853","volume":"8","author":"J Matsukubo","year":"2025","unstructured":"Matsukubo J, Dickson S, Xiao J, Friesen EL, Solmi M, Fiedorowicz JG, et al. Psilocybin dispensaries and online health claims in Canada. JAMA Netw Open. 2025;8:e252853.","journal-title":"JAMA Netw Open"},{"key":"3913_CR38","doi-asserted-by":"crossref","unstructured":"Richard J, Garcia-Romeu A,... Expanded access to psychedelic treatments: comparing American and Canadian policies: pmc.ncbi.nlm.nih.gov; 2025.","DOI":"10.1136\/gpsych-2024-101894"},{"key":"3913_CR39","doi-asserted-by":"crossref","unstructured":"Langlitz N. Experiments in medicalization: psychedelic therapy in Switzerland and Australia. BioSocieties. 2025.","DOI":"10.1057\/s41292-025-00369-y"},{"key":"3913_CR40","doi-asserted-by":"crossref","unstructured":"Dixon Ritchie O, Donley CN, Dixon Ritchie G From prohibited to prescribed: the rescheduling of MDMA and psilocybin in Australia. Drug Science, Policy Law. 2023;9.","DOI":"10.1177\/20503245231198472"},{"key":"3913_CR41","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00213-024-06620-x","volume":"241","author":"JS Aday","year":"2024","unstructured":"Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, et al. Psychedelic-assisted psychotherapy: where is the psychotherapy research?. Psychopharmacology. 2024;241:1517\u201326.","journal-title":"Psychopharmacology"},{"key":"3913_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12152-024-09550-9","volume":"17","author":"N Langlitz","year":"2024","unstructured":"Langlitz N, Gearin AK. Psychedelic therapy as form of life. Neuroethics. 2024;17:14.","journal-title":"Neuroethics"},{"key":"3913_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/15265161.2024.2433457","volume":"25","author":"K Davis","year":"2025","unstructured":"Davis K, Palitsky R, Dunlop BW, George HG, Zarrabi AJ. Psychedelic ethics in palliative care. Am J Bioeth. 2025;25:95\u20138.","journal-title":"Am J Bioeth"},{"key":"3913_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-025-01784-5","volume":"24","author":"S Bertaud","year":"2025","unstructured":"Bertaud S, Wilkinson D, Kelley M. The heart of palliative care is relational: a scoping review of the ethics of care in palliative medicine. BMC Palliat Care. 2025;24:150.","journal-title":"BMC Palliat Care"},{"key":"3913_CR45","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1089\/jpm.2022.0036","volume":"25","author":"WE Rosa","year":"2022","unstructured":"Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, et al. Top ten tips palliative care clinicians should know about psychedelic-assisted therapy in the context of serious illness. J Palliat Med. 2022;25:1273\u201381.","journal-title":"J Palliat Med"},{"key":"3913_CR46","first-page":"462","volume":"9","author":"JH Krystal","year":"2024","unstructured":"Krystal JH, Preller KH, Corlett PR, Anticevic A, Kaye AP. Psychedelics and the neurobiology of meaningfulness. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024;9:462\u20133.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3913_CR47","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/13634615211036388","volume":"59","author":"D Dupuis","year":"2022","unstructured":"Dupuis D. The socialization of hallucinations: cultural priors, social interactions, and contextual factors in the use of psychedelics. Transcult Psychiatry. 2022;59:625\u201337.","journal-title":"Transcult Psychiatry"},{"key":"3913_CR48","unstructured":"Tramacchi D Entheogens and the disincarnate. In: Barlow C, editor. Australian Entheogenic Compendium (Volume One). Australia; 2017."},{"key":"3913_CR49","unstructured":"Grof, S, & Halifax, J (1977). The human encounter with death. E.P. Dutton."},{"key":"3913_CR50","doi-asserted-by":"crossref","unstructured":"Labate B, Cavnar C (Eds) Ayahuasca Shamanism in the Amazon and Beyond. Oxford, UK: Oxford University Press; 2014.","DOI":"10.1093\/acprof:oso\/9780199341191.001.0001"},{"key":"3913_CR51","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3389\/fpsyg.2018.01424","volume":"9","author":"C Timmermann","year":"2018","unstructured":"Timmermann C, Roseman L, Williams L, Erritzoe D, Martial C, Cassol H, et al. DMT models the near-death experience. Front Psychol. 2018;9:1424.","journal-title":"Front Psychol"},{"key":"3913_CR52","unstructured":"Strassman R DMT: the spirit molecule : a doctor's revolutionary research into the biology of near-death and mystical experiences. Rochester, Vermont: Park Street Press; 2001."},{"key":"3913_CR53","doi-asserted-by":"crossref","unstructured":"Letheby C, Gerrans P Self unbound: ego dissolution in psychedelic experience. Neuroscience of Consciousness. 2017;2017:nix016","DOI":"10.1093\/nc\/nix016"},{"key":"3913_CR54","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1177\/1049909111434976","volume":"29","author":"C Granda-Cameron","year":"2012","unstructured":"Granda-Cameron C, Houldin A. Concept analysis of good death in terminally Ill patients. American. J Hosp Palliat Med. 2012;29:632\u20139.","journal-title":"J Hosp Palliat Med"},{"key":"3913_CR55","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1365-2753.2012.01922.x","volume":"18","author":"G Scarre","year":"2012","unstructured":"Scarre G. Can there be a good death?. J Eval Clin Pract. 2012;18:1082\u20136.","journal-title":"J Eval Clin Pract"},{"key":"3913_CR56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jagp.2016.01.135","volume":"24","author":"EA Meier","year":"2016","unstructured":"Meier EA, Gallegos JV, Thomas LP, Depp CA, Irwin SA, Jeste DV. Defining a good death (Successful Dying): literature review and a call for research and public dialogue. Am J Geriatr Psychiatry. 2016;24:261\u201371.","journal-title":"Am J Geriatr Psychiatry"},{"key":"3913_CR57","doi-asserted-by":"crossref","unstructured":"Mathews G, Yang Y, Kwong M Life After Death Today in the United States, Japan, and China; 2022.","DOI":"10.4324\/9781003322467"},{"key":"3913_CR58","doi-asserted-by":"crossref","unstructured":"Goossaert V, Palmer D The Religious Question in Modern China; 2011.","DOI":"10.7208\/chicago\/9780226304182.001.0001"},{"key":"3913_CR59","doi-asserted-by":"publisher","first-page":"20230006","DOI":"10.1515\/ajmedh-2023-0006","volume":"2","author":"ED Jeon","year":"2023","unstructured":"Jeon ED, Jing J. A study of end-of-life care communication and decision-making in China by exploring filial piety and medical information concealment. Asian J Med Humanities. 2023;2:20230006.","journal-title":"Asian J Med Humanities"},{"key":"3913_CR60","doi-asserted-by":"publisher","first-page":"969733024131237","DOI":"10.1177\/09697330241312376","volume":"32","author":"Q Ma","year":"2025","unstructured":"Ma Q, Wu Y, Fang R. Truth-telling, and ethical considerations in terminal care: an Eastern perspective. Nurs Ethics. 2025;32:9697330241312376.","journal-title":"Nurs Ethics"},{"key":"3913_CR61","doi-asserted-by":"publisher","first-page":"102017","DOI":"10.1016\/j.ejon.2021.102017","volume":"54","author":"L Liu","year":"2021","unstructured":"Liu L, Ma L, Chen Z, Geng H, Xi L, McClement S, et al. Dignity at the end of life in traditional Chinese culture: perspectives of advanced cancer patients and family members. Eur J Oncol Nurs. 2021;54:102017.","journal-title":"Eur J Oncol Nurs"},{"key":"3913_CR62","first-page":"338","volume":"14","author":"JB Nie","year":"2012","unstructured":"Nie JB. The fallacy and dangers of dichotomizing cultural differences: the truth about medical truth telling in China. Virtual Mentor. 2012;14:338\u201343.","journal-title":"Virtual Mentor"},{"key":"3913_CR63","doi-asserted-by":"publisher","first-page":"680064","DOI":"10.3389\/fpsyt.2021.680064","volume":"12","author":"N Langlitz","year":"2021","unstructured":"Langlitz N, Dyck E, Scheidegger M, Repantis D. Moral psychopharmacology needs moral inquiry: the case of psychedelics. Front Psychiatry. 2021;12:680064.","journal-title":"Front Psychiatry"},{"key":"3913_CR64","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1017\/S1358246118000474","volume":"83","author":"BD Earp","year":"2018","unstructured":"Earp BD. Psychedelic moral enhancement. R Inst Philosophy. 2018;83:415\u201339.","journal-title":"R Inst Philosophy"},{"key":"3913_CR65","doi-asserted-by":"crossref","unstructured":"Hartogsohn I American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century: The MIT Press; 2020.","DOI":"10.7551\/mitpress\/11888.001.0001"},{"key":"3913_CR66","unstructured":"Zinberg NE Drug, set, and setting : the basis for controlled intoxicant use. New Haven: Yale University Press; 1984."},{"key":"3913_CR67","doi-asserted-by":"crossref","unstructured":"Langdon EJ Yag\u00e9 Among the siona: cultural patterns in visions. In: David LB, Ronald AS, editors. Spirits, Shamans, and Stars. Berlin, New York: De Gruyter Mouton; 1980. p. 63\u201380.","DOI":"10.1515\/9783110821031.63"},{"key":"3913_CR68","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology. 2018;235:399\u2013408.","journal-title":"Psychopharmacology"},{"key":"3913_CR69","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3389\/fpls.2017.01238","volume":"8","author":"FS Barrett","year":"2017","unstructured":"Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR. Qualitative and quantitative features of music reported to support peak mystical experiences during psychedelic therapy sessions. Front Physiol. 2017;8:1238.","journal-title":"Front Physiol"},{"key":"3913_CR70","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/02698811221131989","volume":"37","author":"SM Nayak","year":"2023","unstructured":"Nayak SM, Singh M, Yaden DB, Griffiths RR. Belief changes associated with psychedelic use. J Psychopharmacol. 2023;37:80\u201392. https:\/\/doi.org\/10.1177\/02698811221131989.","journal-title":"J Psychopharmacol"},{"key":"3913_CR71","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/0022167817711304","volume":"57","author":"J Phelps","year":"2017","unstructured":"Phelps J. Developing guidelines and competencies for the training of psychedelic therapists. J Humanist Psychol. 2017;57:450\u201387.","journal-title":"J Humanist Psychol"},{"key":"3913_CR72","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269881108093587","volume":"22","author":"MW Johnson","year":"2008","unstructured":"Johnson MW, Richards WA, Griffiths RR. Human hallucinogen research: guidelines for safety. J Psychopharmacol. 2008;22:603\u201320.","journal-title":"J Psychopharmacol"},{"key":"3913_CR73","doi-asserted-by":"crossref","unstructured":"Wolff M, Evens R, Mertens L, Koslowski M... Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance: frontiersin.org; 2020.","DOI":"10.3389\/fpsyt.2020.00005"},{"key":"3913_CR74","doi-asserted-by":"crossref","unstructured":"Bell KA, Watt RB, Lopez Flores AS Cultural Humility and Psychedelics: A Framework Analysis of Psychedelic-Assisted Therapy Manuals and Practice Guidelines PREPRINT (Version 1). 2025.","DOI":"10.21203\/rs.3.rs-5908748\/v1"},{"key":"3913_CR75","doi-asserted-by":"publisher","first-page":"117863292097058","DOI":"10.1177\/1178632920970580","volume":"13","author":"H-M Lekas","year":"2020","unstructured":"Lekas H-M, Pahl K, Fuller Lewis C. Rethinking cultural competence: shifting to cultural humility. Health Serv Insights. 2020;13:1178632920970580.","journal-title":"Health Serv Insights"},{"key":"3913_CR76","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1503\/cmaj.100874","volume":"182","author":"HM Chochinov","year":"2010","unstructured":"Chochinov HM. Humility and the practice of medicine: tasting humble pie. Can Med Assoc J. 2010;182:1217.","journal-title":"Can Med Assoc J"},{"key":"3913_CR77","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/03057240.2016.1168736","volume":"45","author":"J Li","year":"2016","unstructured":"Li J. Humility in learning: A Confucian perspective. J Moral Educ. 2016;45:147\u201365.","journal-title":"J Moral Educ"},{"key":"3913_CR78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/02791072.2021.1916659","volume":"54","author":"CE Mayer","year":"2022","unstructured":"Mayer CE, LeBaron VT, Acquaviva KD. Exploring the use of psilocybin therapy for existential distress: a qualitative study of palliative care provider perceptions. J Psychoact Drugs. 2022;54:81\u201392.","journal-title":"J Psychoact Drugs"},{"key":"3913_CR79","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/02791072.2019.1581308","volume":"51","author":"E Dyck","year":"2019","unstructured":"Dyck E. Psychedelics and dying care: a historical look at the relationship between psychedelics and palliative care. J Psychoact Drugs. 2019;51:102\u20137.","journal-title":"J Psychoact Drugs"},{"key":"3913_CR80","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/10401334.2021.1877711","volume":"33","author":"D Solchanyk","year":"2021","unstructured":"Solchanyk D, Ekeh O, Saffran L, Burnett-Zeigler IE, Doobay-Persaud A. Integrating cultural humility into the medical education curriculum: strategies for educators. Teach Learn Med. 2021;33:554\u201360.","journal-title":"Teach Learn Med"},{"key":"3913_CR81","doi-asserted-by":"publisher","first-page":"e0284698","DOI":"10.1371\/journal.pone.0284698","volume":"18","author":"ME Gaignard","year":"2023","unstructured":"Gaignard ME, Pautex S, Hurst S. Existential suffering as a motive for assisted suicide: Difficulties, acceptability, management and roles from the perspectives of Swiss professionals. PLoS One. 2023;18:e0284698.","journal-title":"PLoS One"},{"key":"3913_CR82","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/21507740.2023.2188297","volume":"14","author":"D Rosenbaum","year":"2023","unstructured":"Rosenbaum D, Cho M, Schneider E, Hales S. Ethical considerations at the intersection between psychedelic-assisted psychotherapy and medical assistance in dying. AJOB Neurosci. 2023;14:139\u201341.","journal-title":"AJOB Neurosci"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03913-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03913-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03913-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:02:46Z","timestamp":1773406966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03913-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3913"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03913-x","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no financial or non-financial conflicts of interest, and no external party influenced the study design, analysis, or manuscript preparation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}